Cargando…

Assessment of risk factors associated with outpatient parenteral antimicrobial therapy (OPAT) complications: A retrospective cohort study

OBJECTIVE: To characterize factors associated with increased risk of outpatient parenteral antimicrobial therapy (OPAT) complication. DESIGN: Retrospective cohort study. SETTING: Four hospitals within NYU Langone Health (NYULH). PATIENTS: All patients aged ≥18 years with OPAT episodes who were admit...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaul, Christina M., Haller, Matthew, Yang, Jenny, Solomon, Sadie, Wang, Yaojie, Wu, Rong, Meng, Yu, Pitts, Robert A., Phillips, Michael S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672913/
https://www.ncbi.nlm.nih.gov/pubmed/36406163
http://dx.doi.org/10.1017/ash.2022.313
Descripción
Sumario:OBJECTIVE: To characterize factors associated with increased risk of outpatient parenteral antimicrobial therapy (OPAT) complication. DESIGN: Retrospective cohort study. SETTING: Four hospitals within NYU Langone Health (NYULH). PATIENTS: All patients aged ≥18 years with OPAT episodes who were admitted to an acute-care facility at NYULH between January 1, 2017, and December 31, 2020, who had an infectious diseases consultation during admission. RESULTS: Overall, 8.45% of OPAT patients suffered a vascular complication and 6.04% suffered an antimicrobial complication. Among these patients, 19.95% had a 30-day readmission and 3.35% had OPAT-related readmission. Also, 1.58% of patients developed a catheter-related bloodstream infection (CRBSI). After adjusting for key confounders, we found that patients discharged to a subacute rehabilitation center (SARC) were more likely to develop a CRBSI (odds ratio [OR], 4.75; P = .005) and to be readmitted for OPAT complications (OR, 2.89; P = .002). Loss to follow-up with the infectious diseases service was associated with increased risks of CRBSI (OR, 3.78; P = .007) and 30-day readmission (OR, 2.59; P < .001). CONCLUSIONS: Discharge to an SARC is strongly associated with increased risks of readmission for OPAT-related complications and CRBSI. Loss to follow-up with the infectious diseases service is strongly associated with increased risk of readmission and CRBSI. CRBSI prevention during SARC admission is a critically needed public health intervention. Further work must be done for patients undergoing OPAT to improve their follow-up retention with the infectious diseases service.